The advancement in the field of immunotherapeutics has led to a new drive to comprehend the tumor microenvironment. Immunohistochemistry is a robust tool for the investigation of the expression, ...
In immunohistochemistry, colored substrates are used to detect specific proteins within a biological sample. For example, after application of the primary antibody, a second antibody conjugated to an ...
PURPOSE: Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the ...
To be adopted in the routine clinical setting, a biomarker must both demonstrate a clear additional benefit over standard clinical, radiological, and pathological examination (usually to predict ...
Chronic graft-vs-host disease (cGVHD) is a heterogeneous complication of hematopoietic SCT (HSCT) that rarely targets muscle. Although treatment of cGVHD is well studied, the optimal therapy for rare ...
A new study evaluates immunohistochemistry-based subtype classification of breast tumors for the prediction of disease outcome. A study by Paul Pharoah and colleagues published in this week's PLoS ...
Immunohistochemistry (IHC) has continually evolved alongside technological and scientific advances. Because scientists constantly develop and modify their IHC techniques to better answer modern ...
Agilent Technologies Inc. A shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Synergies Biocare Medical has been a ...
Immunohistochemistry (IHC) is an important evaluation tool that falls under the umbrella of immunostaining techniques and exploits antigen–antibody binding to study the status of target molecules in ...
Companion diagnostic immunohistochemistry (IHC) tests do not yet incorporate the tools and principles of laboratory metrology. Basic analytic assay parameters, such as lower limit of detection (LOD) ...
Personalized medicine depends on tools, such as immunohistochemistry (IHC), that identify precise targets in a patient’s disease. Immunohistochemistry (IHC) staining is integral in developing ...
Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results